EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Candidemia in cancer: A retrospective analysis of risk profiles, treatment approaches and outcomes in critical and non-critical care settings

Seemal Aslam, Madiha Ghulam, Ali Anjum, Hamayal Masood

Infectious Diseases Journal of Pakistan · 30.03.2026 · 35 (1) · 3-9

DOI: 10.61529/idjp.v35i1.431 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infectious Diseases Journal of Pakistan, online erschienen am 30.03.2026. Verfasst von Seemal Aslam und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Candidemia is a significant contributor to morbidity and mortality in cancer patients. This study aimed to compare the clinical characteristics, species distribution, risk factors, complications, and outcomes of candidemia between intensive care unit (ICU) and non-ICU settings Material and Methods: This retrospective study was conducted at a tertiary care oncology hospital in Lahore over a three-year period (January 2020–December 2022). A total of 175 cancer patients with blood culture–confirmed candidemia were included. Patients were stratified into ICU and non-ICU groups to compare demographic characteristics, species distribution, risk factors, complications, and clinical outcomes.

Results

Candida tropicalis (40.6%) was the most frequently isolated species, followed by Candida albicans (34.3%). Common risk factors included recent antibiotic use (98.3%) and central venous catheterization (72%). ICU patients were significantly older (median age 42 vs. 26 years, p = 0.007) and experienced higher in-hospital mortality (77.3% vs. 43.1%, p < 0.001). No particular Candida species was associated with increased mortality. Recent chemotherapy within 14 days was significantly linked to higher mortality (p = 0.045).

Conclusion

Candidemia in cancer patients is associated with high mortality, particularly among ICU admissions. The predominance of non-albicans species and adverse outcomes in critically ill patients emphasize the need for early recognition and timely, targeted antifungal therapy. Keywords: Antifungal therapy, Cancer, Candidemia, Intensive care unit, Mortality, Non-albicans Candida

Zitieren

APA

Aslam, S., Ghulam, M., Anjum, A., & Masood, H. (2026). Candidemia in cancer: A retrospective analysis of risk profiles, treatment approaches and outcomes in critical and non-critical care settings. Infectious Diseases Journal of Pakistan, 35(1), 3-9. https://doi.org/10.61529/idjp.v35i1.431

Vancouver

Aslam S, Ghulam M, Anjum A, Masood H. Candidemia in cancer: A retrospective analysis of risk profiles, treatment approaches and outcomes in critical and non-critical care settings. Infectious Diseases Journal of Pakistan. 2026;35(1):3-9. doi:10.61529/idjp.v35i1.431

BibTeX
@article{Aslam2026,
  author = {Aslam, Seemal and Ghulam, Madiha and Anjum, Ali and Masood, Hamayal},
  title = {Candidemia in cancer: A retrospective analysis of risk profiles, treatment approaches and outcomes in critical and non-critical care settings},
  journal = {Infectious Diseases Journal of Pakistan},
  year = {2026},
  volume = {35},
  number = {1},
  pages = {3--9},
  doi = {10.61529/idjp.v35i1.431}
}
Kostenlos starten →